Your source for scientific, technical, and purchasing information for the gold standard immunochemical marker for hypoxia in solid tissues.
Hypoxyprobe™, Inc.. NPI, Inc announces the creation of Hypoxyprobe™, Inc., a spin-off of NPI’s Hypoxyprobe Division dedicated to the development of Hypoxyprobe™ technology for the detection and therapeutic targeting of tissue hypoxia. Scientific, technical, and purchasing support remain unchanged.
Hypoxyprobe™ Gemini Kit. Hypoxyprobe™, Inc has released the Hypoxyprobe™ Gemini Kit, a new dual marker kit that permits investigators to follow changes in tissue hypoxia with a single biopsy sample.
Buy Hypoxyprobe™ Kits from Hypoxyprobe, Inc., the international supplier for Hypoxyprobe™ technology. See the Hypoxyprobe Store for Kit descriptions, contact and ordering information.
Hypoxyprobe™ Kits have been used in over 350 published studies. Applications include studies of hypoxia in normal tissue physiology, pathophysiology and malignancy.
Hypoxyprobe™ Kits contain a choice of mouse monoclonal, FITC-conjugated mouse monoclonal or rabbit antibodies and can be studied by means of immunofluorescence, immunoperoxidase, immunoblotting, western analysis, flow cytometry or ELISA of isolated cells in vitro or tissues in vivo.
Hypoxyprobe™ Technology was invented by James A. Raleigh. He is available for consultation at lowpo2@yahoo.com or 919-260-6398. Answers to questions about Hypoxyprobe use can also be found via FAQ.